Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$226.52 - $324.64 $658,493 - $943,728
2,907 New
2,907 $943,000
Q4 2022

Feb 13, 2023

BUY
$164.02 - $259.76 $209,125 - $331,194
1,275 New
1,275 $320,000
Q1 2021

May 12, 2021

SELL
$182.45 - $249.25 $678,531 - $926,960
-3,719 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$119.35 - $200.46 $1.16 Million - $1.95 Million
-9,734 Reduced 72.36%
3,719 $700,000
Q3 2020

Nov 12, 2020

SELL
$87.5 - $130.91 $693,700 - $1.04 Million
-7,928 Reduced 37.08%
13,453 $1.74 Million
Q2 2020

Aug 13, 2020

SELL
$49.5 - $97.93 $464,755 - $919,464
-9,389 Reduced 30.51%
21,381 $1.86 Million
Q1 2020

May 12, 2020

SELL
$41.62 - $89.92 $69,713 - $150,616
-1,675 Reduced 5.16%
30,770 $1.86 Million
Q4 2019

Feb 11, 2020

BUY
$52.12 - $75.0 $484,038 - $696,525
9,287 Added 40.1%
32,445 $2.41 Million
Q3 2019

Nov 12, 2019

SELL
$61.02 - $70.19 $184,219 - $211,903
-3,019 Reduced 11.53%
23,158 $1.41 Million
Q2 2019

Aug 14, 2019

BUY
$47.07 - $60.71 $1.23 Million - $1.59 Million
26,177 New
26,177 $1.59 Million

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.12B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.